The role of CRISPR-Cas in advancing precision periodontics.
CRISPR
Cas9
periodontal disease
precision periodontics
Journal
Journal of periodontal research
ISSN: 1600-0765
Titre abrégé: J Periodontal Res
Pays: United States
ID NLM: 0055107
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
revised:
23
11
2020
received:
22
09
2020
accepted:
22
12
2020
pubmed:
17
1
2021
medline:
19
5
2021
entrez:
16
1
2021
Statut:
ppublish
Résumé
The significant advancement of molecular biology has revolutionized medicine and provided important technologies to further clinical research development. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) are DNA sequences derived from bacteriophages which have previously infected the bacterial species. The CRISPR-Cas system plays a key role in bacterial defense by detecting and destroying DNA fragments during subsequent bacteriophage invasions. The Cas9 enzyme recognizes and cleaves new invading CRISPR-complementary DNA sequences. Researchers have taken advantage of this biological device to manipulate microbes' genes and develop novel therapeutics to tackle systemic disease. In this review, we discuss the potential of utilizing CRISPR-Cas systems in the periodontal field to develop personalized periodontal care. We summarize promising attempts to bring this technology to the clinical setting. Finally, we provide insights regarding future developments to best utilize the CRISPR-Cas systems to advance precision periodontics. Although further research is imperative to evaluate the safety and potential of using CRISPR-Cas to develop precision periodontics approaches, few studies showed promising data to support the investment into this important technology in the dental sector. CRISPR-Cas9 can be a useful tool to create knockouts in vitro and in vivo as a screening tool to identify cellular pathways involved in the pathogenesis of periodontitis. Alternative CRISPR systems such as CRISPRa, CRISPRi, and Cas13 can be used to modify the transcriptome and gene expression of genes involved in periodontitis progression. CRISPR systems such as Cas3 can be used to target the periodontal biofilm and to develop new strategies to reduce or eliminate periodontal pathogens. Currently, the utility of CRISPR-Cas applications in clinical settings is limited. Through this review, we hope to foster further discussion in the periodontal research and clinical communities with respect to the potential clinical application of novel, CRISPR-Cas based, therapeutics for periodontitis.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
454-461Informations de copyright
© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Références
Jepsen S, Caton JG, Albandar JM, et al. Periodontal manifestations of systemic diseases and developmental and acquired conditions: Consensus report of workgroup 3 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Periodontol. 2018;89:S237-S248.
Fine N, Hassanpour S, Borenstein A, et al. Distinct Oral Neutrophil Subsets Define Health and Periodontal Disease States. J Dent Res. 2016;95(8):931-938.
Fine N, Chadwick JW, Sun C, et al. Periodontal Inflammation Primes the Systemic Innate Immune Response. J Dent Res. 2020;1-8. https://doi.org/10.1177%2F0022034520963710
Cheng R, Hu T, Bhowmick NA. Be resistant to apoptosis: a host factor from gingival fibroblasts. Cell Death Dis. 2015;6(12):e2009.
Zhang S, Yu N, Arce RM. Periodontal inflammation: Integrating genes and dysbiosis. Periodontology 2000. 2020;82(1):129-142.
Pan W, Wang Q, Chen Q. The cytokine network involved in the host immune response to periodontitis. Int J Oral Sci. 2019;11(3):30.
Kornman KS. Mapping the Pathogenesis of Periodontitis: A New Look. J Periodontol. 2008;79(8):1560-1568.
Van Dyke TE, Bartold PM, Reynolds EC. The Nexus Between Periodontal Inflammation and Dysbiosis. Frontiers in Immunology. 2020;11. http://dx.doi.org/10.3389/fimmu.2020.00511
Lasserre JF, Brecx MC, Toma S. Oral Microbes, Biofilms and Their Role in Periodontal and Peri-Implant Diseases. Materials. 2018;11(10):1802.
Oveisi M, Shifman H, Fine N, et al. Novel Assay To Characterize Neutrophil Responses to Oral Biofilms. Infect Immun. 2019;87(2).e00790-18.
Loesche WJ, Giordano JR, Hujoel P, Schwarcz J, Smith BA. Metronidazole in periodontitis: reduced need for surgery. J Clin Periodontol. 1992;19(2):103-112.
Ryder MI, Couch ET, Chaffee BW. Personalized periodontal treatment for the tobacco- and alcohol-using patient. Periodontology 2000. 2018;78(1):30-46.
Bartold PM. Lifestyle and periodontitis: The emergence of personalized periodontics. Periodontology 2000. 2018;78(1):7-11.
Yu N, Yang J, Mishina Y, Giannobile WV. Genome Editing: A New Horizon for Oral and Craniofacial Research. J Dent Res. 2019;98(1):36-45.
Silva G, Poirot L, Galetto R, et al. Meganucleases and other tools for targeted genome engineering: perspectives and challenges for gene therapy. Curr Gene Ther. 2011;11(1):11-27.
Gupta RM, Musunuru K. Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9. J Clin Invest. 2014;124(10):4154-4161.
Horvath P, Barrangou R. CRISPR/Cas, the immune system of bacteria and archaea. Science. 2010;327(5962):167-170.
Hryhorowicz M, Lipianki D, Zeyland J, Slomski R. CRISPR/Cas9 Immune System as a Tool for Genome Engineering. Arch Immunol Ther Ex. 2017;65(3):233-240.
Beaudet AL, Meng L. Gene-targeting pharmaceuticals for single-gene disorders. Hum Mol Genet. 2016;25(R1):R18-R26.
Morishige S, Mizuno S, Ozawa H, et al. CRISPR/Cas9-mediated gene correction in hemophilia B patient-derived iPSCs. Int J Hematol. 2020;111(2):225-233.
Schwank G, Koo BK, Sasselli V, et al. Functional Repair of CFTR by CRISPR/Cas9 in Intestinal Stem Cell Organoids of Cystic Fibrosis Patients. Cell Stem Cell. 2013;13(6):653-658.
Zhang P, Zhang W, Zhang D, et al. 25-Hydroxyvitamin D3 -enhanced PTPN2 positively regulates periodontal inflammation through the JAK/STAT pathway in human oral keratinocytes and a mouse model of type 2 diabetes mellitus. J Periodontal Res. 2018;53(3):467-477.
Yoon Y, Kim TJ, Lee JM, Kim DY. SOD2 is upregulated in periodontitis to reduce further inflammation progression. Oral Dis. 2018;24(8):1572-1580.
Xie J, Li Q, Zhu XH, Gao YY, Zhao WH. IGF2BP1 promotes LPS-induced NF kappa B activation and pro-inflammatory cytokines production in human macrophages and monocytes. Biochem Bioph Res Co. 2019;513(4):820-826.
Zhang P, Wang Q, Nie L, et al. Hyperglycemia-induced inflamm-aging accelerates gingival senescence via NLRC4 phosphorylation. J Biol Chem. 2019;294(49):18807-18819.
Vega BA, Schober LT, Kim T, Belinka BA Jr, Kachlany SC. Aggregatibacter actinomycetemcomitans Leukotoxin (LtxA) Requires Death Receptor Fas, in Addition to LFA-1, To Trigger Cell Death in T Lymphocytes. Infect Immun. 2019;87(8):e00309-19.
Mehravar M, Roshandel E, Salimi M, et al. Utilization of CRISPR/Cas9 gene editing in cellular therapies for lymphoid malignancies. Immunol Lett. 2020;226:71-82.
Santos R, Amaral O. Advances in Sphingolipidoses: CRISPR-Cas9 Editing as an Option for Modelling and Therapy. Int J Mol Sci. 2019;20(23):5897.
Iqubal A, Iqubal MK, Khan A, Ali J, Baboota S, Haque SE. Gene Therapy, A Novel Therapeutic Tool for Neurological Disorders: Current Progress, Challenges and Future Prospective. Curr Gene Ther. 2020;20(3):184-194.
Buiani R. Gene Editing, Sexual Reproduction, and the Arts: The Present, the Future, and the Imagined. Adv Exp Med Biol. 2020;1195:177.
Benakanakere MR, Finoti LS, Tanaka U, Grant GR, Scarel-Caminaga RM, Kinane DF. Investigation of the functional role of human Interleukin-8 gene haplotypes by CRISPR/Cas9 mediated genome editing. Sci Rep. 2016;6:31180.
Mlachkova A, Popova C, Doseva V. Presence of IL-8 Gene Polymorphism and IL-8 Serum Levels in Patients with Chronic Periodontitis - Literature Review. Folia Med (Plovdiv). 2020;62(2):253-257.
Qi LS, Larson MH, Gilbert LA, et al. Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression. Cell. 2013;152(5):1173-1183.
Zalatan JG, Lee ME, Almeida R, et al. Engineering Complex Synthetic Transcriptional Programs with CRISPR RNA Scaffolds. Cell. 2015;160(1-2):339-350.
Abudayyeh OO, Gootenberg JS, Essletzbichler P, et al. RNA targeting with CRISPR-Cas13. Nature. 2017;550(7675):280-284.
Cox DBT, Gootenberg JS, Abudayyeh OO, et al. RNA editing with CRISPR-Cas13. Science. 2017;358(6366):1019-1027.
Gong T, Tang BY, Zhou XD, et al. Genome editing in Streptococcus mutans through self-targeting CRISPR arrays. Mol Oral Microbiol. 2018;33(6):440-449.
Selle K, Fletcher JR, Tuson H, et al. In Vivo Targeting of Clostridioides difficile Using Phage-Delivered CRISPR-Cas3 Antimicrobials. Mbio. 2020;11(2).e00019-20.
Zhou H, Zhao H, Zheng J, et al. CRISPRs provide broad and robust protection to oral microbial flora of gingival health against bacteriophage challenge. Protein Cell. 2015;6(7):541-545.
Pride DT, Sun CL, Salzman J, et al. Analysis of streptococcal CRISPRs from human saliva reveals substantial sequence diversity within and between subjects over time. Genome Res. 2011;21(1):126-136.
Tang BY, Gong T, Zhou XD, et al. Deletion of cas3 gene in Streptococcus mutans affects biofilm formation and increases fluoride sensitivity. Arch Oral Biol. 2019;99:190-197.
Solbiati J, Duran-Pinedo A, Rocha FG, Gibson FC, Frias-Lopez J. Virulence of the Pathogen Porphyromonas gingivalis Is Controlled by the CRISPR-Cas Protein Cas3. Msystems. 2020;5(5):e00852-20.
Nakanishi H, Nonaka S, Wu Z. Microglial cathepsin B and Porphyromonas gingivalis gingipains as potential therapeutic targets for sporadic Alzheimer's disease. CNS Neurol Disord Drug Targets. 2020;19(7):495-502.
Manoil D, Bostanci N, Mumcu G, et al. Novel and known periodontal pathogens residing in gingival crevicular fluid are associated with rheumatoid arthritis. J Periodontol. 2020;1-12. https://doi.org/10.1002/JPER.20-0295
Mulhall H, Huck O, Amar S. Porphyromonas gingivalis, a Long-Range Pathogen: Systemic Impact and Therapeutic Implications. Microorganisms. 2020;8(6):1-15.
Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat Rev Immunol. 2015;15(1):30-44.
Chen T, Olsen I. Porphyromonas gingivalis and its CRISPR-Cas system. J Oral Microbiol. 2019;11(1):1638196.
Cho SW, Kim S, Kim Y, et al. Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases. Genome Res. 2014;24(1):132-141.
Pattanayak V, Lin S, Guilinger JP, Ma E, Doudna JA, Liu DR. High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nat Biotechnol. 2013;31(9):839-843.
Plaza Reyes A, Lanner F. Towards a CRISPR view of early human development: applications, limitations and ethical concerns of genome editing in human embryos. Development. 2017;144(1):3-7.
Kleinstiver BP, Pattanayak V, Prew MS, et al. High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects. Nature. 2016;529(7587):490-495.
Slaymaker IM, Gao L, Zetsche B, Scott DA, Yan WX, Zhang F. Rationally engineered Cas9 nucleases with improved specificity. Science. 2016;351(6268):84-88.
Lin Y, Wu JH, Gu WH, et al. Exosome-Liposome Hybrid Nanoparticles Deliver CRISPR/Cas9 System in MSCs. Adv Sci. 2018;5(4):1700611.
Zhen S, Li X. Liposomal delivery of CRISPR/Cas9. Cancer Gene Ther. 2020;27(7-8):515-527.
Dhadse P, Gattani D, Mishra R. The link between periodontal disease and cardiovascular disease: How far we have come in last two decades ? J Indian Soc Periodontol. 2010;14(3):148-154.
Nwizu N, Wactawski-Wende J, Genco RJ. Periodontal disease and cancer: Epidemiologic studies and possible mechanisms. Periodontology 2000. 2020;83(1):213-233.
Fagundes NCF, Almeida APCPSC, Vilhena KFB, Magno MB, Maia LC, Lima RR. Periodontitis As A Risk Factor For Stroke: A Systematic Review And Meta-Analysis. Vasc Health Risk Man. 2019;15:519-532.
Ding F, Wu D, Han X, Cheng LJ, Sun Z, Lv YL. Oral hygiene and periodontal conditions in the Chinese patients with aortic aneurysm. Bmc. Oral Health. 2018;18.